Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 43.62%1.34B | 9.54%861M | 63.20%643M | -16.94%3.41B | -26.61%1.3B | -17.65%933M | 263.89%786M | -60.16%394M | -17.20%4.11B | 1.15%1.77B |
| Net profit before non-cash adjustment | 20.25%980M | 19.61%549M | 143.48%616M | 15.25%2.34B | 234.12%816.51M | -35.27%815M | 8.77%459M | 134.26%253M | -24.22%2.03B | -59.96%244.38M |
| Total adjustment of non-cash items | -47.01%124M | 18.70%622M | 6.70%557M | 26.86%1.71B | -21.73%431.12M | 270.80%234M | 55.95%524M | -12.85%522M | -28.33%1.35B | 45.38%550.79M |
| -Depreciation and amortization | -0.85%349M | -2.48%354M | -3.00%356M | 1.45%1.45B | -1.40%370.75M | -0.56%352M | 1.68%363M | 6.38%367M | 4.33%1.43B | 5.17%376.03M |
| -Reversal of impairment losses recognized in profit and loss | 77.78%32M | -8.33%33M | -350.00%-18M | 55.20%100.01M | 186.79%50.01M | 63.64%18M | 56.52%36M | -130.77%-4M | -19.07%64.44M | 150.72%17.44M |
| -Share of associates | -740.00%-42M | 77.78%-2M | -42.86%8M | 170.02%27.93M | 287.64%27.93M | 68.75%-5M | -28.57%-9M | 800.00%14M | 22.80%-39.88M | -173.19%-14.88M |
| -Disposal profit | -19.01%-482M | 11.11%-8M | -2,333.33%-67M | 34.99%-709.63M | -601.79%-298.63M | 54.70%-405M | 94.94%-9M | -86.96%3M | -99.40%-1.09B | 28.38%-42.55M |
| -Net exchange gains and losses | 94.74%-1M | -200.00%-51M | 266.67%66M | -152.45%-22.3M | -73.61%-4.3M | -211.76%-19M | -133.33%-17M | 178.26%18M | 181.54%42.52M | 97.60%-2.48M |
| -Pension and employee benefit expenses | 27.27%14M | 66.67%15M | 0.00%10M | 1.36%39.96M | 191.03%9.96M | 175.00%11M | 12.50%9M | -58.33%10M | 29.54%39.42M | -53.97%3.42M |
| -Deferred income tax | -10.86%271M | 72.06%234M | 96.77%183M | 10.67%795.81M | 73.96%262.81M | -16.02%304M | 130.51%136M | -36.73%93M | -11.11%719.08M | 13.65%151.08M |
| -Other non-cash items | 22.73%-17M | 213.33%47M | -9.52%19M | -85.44%26.61M | -79.91%12.61M | -188.00%-22M | -34.78%15M | -70.83%21M | -24.35%182.74M | 9.00%62.74M |
| Changes in working capital | 303.45%236M | -57.36%-310M | -39.11%-530M | -189.09%-644.42M | -94.90%49.59M | -1,154.55%-116M | 63.65%-197M | -235.11%-381M | 83.95%723.36M | 28.24%972.36M |
| -Change in receivables | 140.64%115M | 161.97%44M | 30.63%-222M | -155.58%-338.96M | 199.46%335.04M | -148.63%-283M | 85.74%-71M | -177.29%-320M | 86.08%609.88M | 254.88%111.88M |
| -Change in inventory | -62.32%26M | -386.11%-175M | -127.52%-248M | -230.72%-317.64M | -149.52%-241.64M | 238.00%69M | -1,700.00%-36M | 43.52%-109M | 175.81%243M | -32.36%488M |
| -Change in payables | 0.00%94M | -102.27%-178M | -209.80%-56M | 109.24%12.34M | -112.12%-44.66M | 117.94%94M | -114.63%-88M | -19.05%51M | -133.79%-133.61M | 239.85%368.39M |
| -Changes in other current assets | -75.00%1M | 50.00%-1M | -33.33%-4M | -103.91%-160K | -79.46%840K | 33.33%4M | -100.00%-2M | -50.00%-3M | 143.54%4.09M | 573.81%4.09M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 59.53%-121M | 52.88%-49M | -64.29%-92M | 39.17%-614.14M | 51.61%-155.14M | -67.04%-299M | 67.40%-104M | 70.68%-56M | 21.19%-1.01B | 9.70%-320.59M |
| Other operating cash inflow (outflow) | 0.00%-10M | 12.50%-7M | -14.29%-8M | -78.79%-37.44M | -276.18%-12.44M | 16.67%-10M | 11.11%-8M | 0.00%-7M | 36.37%-20.94M | 171.26%7.06M |
| Operating cash flow | 93.75%1.21B | 19.44%805M | 64.05%543M | -10.29%2.76B | -22.31%1.13B | -33.76%624M | 701.79%674M | -58.15%331M | -15.62%3.07B | 5.18%1.45B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -0.61%-497M | -2.54%-444M | 26.03%-304M | 6.74%-1.88B | 14.99%-543.86M | 2.76%-494M | 13.75%-433M | -11.68%-411M | -24.82%-2.02B | -18.81%-639.78M |
| Net intangibles purchase and sale | -50.00%-15M | 233.33%12M | -185.71%-20M | -131.38%-74.39M | -109.02%-48.39M | -66.67%-10M | -350.00%-9M | -600.00%-7M | -167.18%-32.15M | -2,141.05%-23.15M |
| Net business purchase and sale | ---54M | ---22M | ---249M | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | -0.42%-2.4M | -0.72%-1.4M | ---- | ---- | ---- | 33.49%-2.39M | ---1.39M |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | --2.31M | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | 0.00%1M | 100.00%2M | 100.00%2M | -40.42%7.43M | 842.55%4.43M | -66.67%1M | -88.89%1M | --1M | -19.80%12.47M | 204.21%470K |
| Interest received (cash flow from investment activities) | 0.00%6M | -16.67%5M | -14.29%6M | 13.86%25.84M | 20.12%6.84M | -40.00%6M | 100.00%6M | 75.00%7M | 84.48%22.7M | 32.37%5.7M |
| Net changes in other investments | 45.94%575M | ---1M | ---1M | -53.81%640.85M | 77,839.62%247.85M | -66.89%394M | ---- | ---- | 387.28%1.39B | 100.69%318K |
| Investing cash flow | 113.46%14M | -2.75%-448M | -38.05%-566M | -103.58%-1.28B | 49.50%-332.21M | -115.12%-104M | -47.80%-436M | -12.33%-410M | 48.17%-629.83M | -36.69%-657.83M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -141.38%-910M | 164.33%452M | -71.54%142M | 93.12%-70.73M | -13.78%-363.73M | 73.53%-377M | -76.83%171M | 2,269.57%499M | -141.32%-1.03B | 5.22%-319.67M |
| Increase or decrease of lease financing | -150.00%-15M | 36.36%-14M | 0.00%-9M | 9.88%-48.65M | 31.41%-11.65M | 45.45%-6M | -15.79%-22M | -28.57%-9M | -105.76%-53.98M | -224.42%-16.98M |
| Issuance fees | --0 | --0 | ---2M | --0 | --0 | --0 | --0 | --0 | -241.49%-15.56M | ---- |
| Cash dividends paid | --0 | ---- | ---- | -76.53%-1.13B | -43.53%-322.18M | --0 | ---418M | ---394M | 58.49%-642.47M | 67.55%-224.47M |
| Cash dividends for minorities | -100.00%-16M | -100.00%-6M | -1,000.00%-11M | 59.74%-21.76M | 48.77%-9.76M | 27.27%-8M | 86.36%-3M | 50.00%-1M | 30.97%-54.04M | 37.12%-19.04M |
| Interest paid (cash flow from financing activities) | 21.43%-55M | 21.25%-63M | 16.67%-60M | 12.51%-284.74M | 20.02%-62.74M | 19.54%-70M | 3.61%-80M | 6.49%-72M | -71.82%-325.45M | -13.01%-78.45M |
| Net other fund-raising expenses | 0.00%-62M | --0 | 0.00%-62M | -0.28%-124.3M | -831.71%-300K | 0.00%-62M | --0 | 0.00%-62M | 0.82%-123.96M | 115.79%41K |
| Financing cash flow | -102.29%-1.06B | -25.28%-441M | 94.87%-2M | 24.94%-1.68B | -14.28%-770.35M | 67.21%-523M | -279.59%-352M | 77.19%-39M | 6.40%-2.24B | 40.79%-674.12M |
| Net cash flow | ||||||||||
| Beginning cash position | -7.63%557M | -10.77%638M | -24.70%625M | 30.77%830.38M | -13.82%605M | -9.73%603M | -19.12%715M | 30.71%830M | 5.38%634.99M | -24.92%702M |
| Current changes in cash | 5,600.00%165M | 26.32%-84M | 78.81%-25M | -203.42%-207.92M | -77.81%27.08M | -108.57%-3M | 45.97%-114M | -146.27%-118M | 533.79%201.05M | 151.44%122.05M |
| Effect of exchange rate changes | -660.00%-28M | 50.00%3M | 1,166.67%38M | 151.52%2.92M | -211.75%-7.08M | 600.00%5M | 140.00%2M | 150.00%3M | -899.72%-5.66M | 2,270.55%6.34M |
| End cash Position | 14.71%694M | -7.63%557M | -10.77%638M | -24.69%625.38M | -24.69%625.38M | -13.82%605M | -9.73%603M | -19.12%715M | 30.77%830.38M | 30.77%830.38M |
| Free cash flow | 522.02%678M | 58.01%365M | 238.83%143M | -24.30%716.4M | -33.82%479.4M | -74.41%109M | 137.44%231M | -124.94%-103M | -50.60%946.38M | -4.92%724.38M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.